62 results
Page 2 of 4
8-K
EX-99.1
esxpqcnk
5 May 23
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:30am
8-K
EX-99.1
kj2c0u 8gqr5pg6zk
8 Dec 22
Regulation FD Disclosure
8:19am
8-K
EX-99.1
btkibjq31
22 Nov 22
Regulation FD Disclosure
5:26pm
8-K
EX-99.1
5782zicwm
22 Nov 22
Regulation FD Disclosure
7:31am
8-K
EX-99.1
gfg4l1 j7kzjujy
9 Nov 22
Arvinas Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:28am
8-K
EX-99.2
11mxwu5lo63033ni
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.2
lc3xdx40q 71ifs
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-1.1
zbw5pdk
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.1
cxpaiq jwtp9
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.2
pjt7u0 1cnhjl
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.2
zparz7sl
14 Dec 20
Regulation FD Disclosure
7:30am
8-K
EX-99.2
0t2 rpyvtj6
29 May 20
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader
7:06am